| Literature DB >> 35745531 |
Osvalda De Giglio1, Francesco Triggiano1, Francesca Apollonio1, Chrysovalentinos Pousis1, Carla Calia1, Giusy Diella1, Francesco Bagordo2, Sapia Murgolo3, Tiziana Grassi4, Cristina De Ceglie3, Silvia Brigida3, Giuseppina La Rosa5, Pamela Mancini5, Giusy Bonanno Ferraro5, Antonella De Donno4, Giuseppe Mascolo3,6, Maria Clementina Caputo3, Maria Teresa Montagna1.
Abstract
This study evaluated whether some chemical and microbial contaminants in treated sewage effluents from two wastewater treatment plants (WWTP) reached the groundwater when they drained through a fractured karst vadose zone (WWTP-K) and a porous vadose zone (WWTP-P). Forty-five samples of sewage water (SW), treated water (TW), and monitoring well (MW), collected from WWTP-P (24) and WWTP-K (21), were analyzed for a range of microbiological and chemical properties. The E. coli and Salmonella counts were below the limits outlined in the Legislative Decree 152/06 in effluents from both types of WWTP. Enteric viruses were found in 37.5% and 12.5% of the SW and TW from WWTP-P, respectively. The percentages of Pepper mild mottle virus isolated were higher in TW (62.5% in WWTP-P, 85.7% in WWTP-K) than in SW and MW. The residual concentrations of contaminants of emerging concern (CEC) of each drug category were higher in the MW downstream of WWTP-K than of WWTP-P. Our results showed that the porous vadose zone was more effective at reducing the contaminant loads than the fractured karst one, especially the CEC, in the effluent. The legislation should include other parameters to minimize the risks from treated effluent that is discharged to soil.Entities:
Keywords: chemicals; contaminants of emerging concern; enteric viruses; groundwater; karst aquifer; porous aquifer; wastewater treatment plant
Year: 2022 PMID: 35745531 PMCID: PMC9228818 DOI: 10.3390/pathogens11060677
Source DB: PubMed Journal: Pathogens ISSN: 2076-0817
Chemical and physical parameters, reported as mean values (± standard deviation), measured in the sewage water (SW), treated water (TW), and monitoring well (MW) samples in the porous aquifer (WWTP-P), and karst fractured aquifer (WWTP-K).
| Parameters | Unit of Measure | Limit | WWTP-P | WWTP-K | ||||
|---|---|---|---|---|---|---|---|---|
| TW | SW | TW | MW | SW | TW | MW | ||
| pH | 6–8 | 7.7 ± 0.3 | 7.8 ± 0.2 | 7.4 ± 0.1 | 7.7 ± 0.3 | 7.4 ± 0.3 | 7.4 ± 0.3 | |
| Conductivity | (μS/cm) | - | 1745 ± 264 | 1318 ± 319 | 568 ± 36 | 1699 ± 210 | 1080 ± 265 | 1163 ± 35 |
| BOD5 | (mg/L) | 20 | 640 ± 207 | 11.3 ± 4.6 | 0 | 580 ± 142 | 10.3 ± 2.5 | 0 |
| COD | (mg/L) | 100 | 935 ± 267 | 42.9 ± 45.5 | 0 | 859 ± 215 | 27.5 ± 6.5 | 2.5 ± 3.1 |
| TN | (mg/L) | 15 | 106.4 ± 16.7 | 14.0 ± 17.3 | 27.1 ± 2.2 * | 74.1 ± 11.6 | 14.4 ± 9.2 | 26.4 ± 2.3 * |
| TP | (mg/L) | 2 | 12.3 ± 4.0 | 3.4 ± 3.7 | ND | 10.7 ± 3.6 | 2.1 ± 0.7 | ND |
BOD5: biochemical oxygen demand, COD: chemical oxygen demand, TN: total nitrogen, * as nitrates (NO3−), TP: total phosphorus, ND: not detected.
Average concentrations (±SD) of bacterial parameters in the treated water (TW) and monitoring well (MW) samples of the porous (WWTP-P) and the karst fractured (WWTP-K) aquifers.
| Bacteria | Unit of Measure | WWTP-P | WWTP-K | ||
|---|---|---|---|---|---|
| TW | MW | TW | MW | ||
|
| CFU/100 mL | 893 ± 1138 | <1 | 6 ± 5 | <1 |
| Enterococci | CFU/100 mL | 16.1 ± 30 | <1 | 5 ± 11 | <1 |
|
| CFU/100 mL | 3 ± 3 | 2 ± 5 | 5 ± 2 | <1 |
|
| CFU/250 mL | 3 ± 6 | 463 ± 1228 | 34.0 ± 89 | 5750 ± 7599 |
(P/T) = number of positive samples/number of analyzed samples.
Percentage of virus positive samples in the sewage water (SW), treated wastewater (TW), and monitoring well (MW) samples from the porous (WWTP-P) and the karst-fractured (WWTP-K) aquifers, determined by PCR assay.
| WWTP-P | WWTP-K | |||||
|---|---|---|---|---|---|---|
| Virus | SW | TW | MW | SW | TW | MW |
| AdV | 0 (0) | 0 (0) | 0 (0) | 5 (71.4) | 3 (42.9) | 1 (14.3) |
| NoV-GI | 1 (12.5) | 0 (0) | 0 (0) | 2 (28.6) | 0 (0) | 0 (0) |
| NoV-GII | 1 (12.5) | 1 (12.5) | 0 (0) | 5 (71.4) | 3 (42.9) | 0 (0) |
| EV | 1 (12.5) | 0 (0) | 0 (0) | 4 (57.1) | 0 (0) | 0 (0) |
| HEV | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
| HAV | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
| RoV | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
| PMMoV | 4 (50) | 5 (62.5) | 0 (0) | 5 (71.4) | 6 (85.7) | 3 (42.9) |
AdV: adenovirus, NoV: norovirus; EV: enterovirus; HAV: hepatitis A virus; HEV: hepatitis E virus; RoV: rotavirus; PMMoV: pepper mild mottle virus.
Mean CEC concentrations (± standard deviation) and the related pharmacological categories (in bold) in the treated wastewater (TW) and monitoring well (MW) samples of the porous (WWTP-P) and the karst fractured (WWTP-K) aquifers.
| Name | WWTP-P | WWTP-K | ||||
|---|---|---|---|---|---|---|
| TW (μg/L) | MW (μg/L) | RC (%) | TW (μg/L) | MW (μg/L) | RC (%) | |
|
|
|
|
|
|
|
|
| Clarithromycin | 0.04 ± 0.05 | 0.00 ± 0.01 | 3.33 ± 8.16 | 0.10 ± 0.05 | 0.00 ± 0.01 | 1.66 ± 4.39 |
| Climbazol | 0.02 ± 0.03 | 0.00 | 0.00 ± 0.00 | 0.08 ± 0.03 | 0.04 ± 0.05 | 52.25 ± 36.76 |
| Fluconazole | 0.62 ± 0.28 | 0.01 ± 0.01 | 2.12 ± 2.54 | 0.38 ± 0.14 | 0.43 ± 0.11 | 122.16 ± 33.04 |
| Levofloxacin | 0.84 ± 0.60 | 0.00 | 0.00 ± 0.00 | 1.89 ± 1.19 | 0.01 ± 0.02 | 0.89 ± 1.87 |
|
|
|
|
|
|
|
|
| Carbamazepine | 0.39 ± 0.08 | 0.01 ± 0.01 | 2.34 ± 2.66 | 0.32 ± 0.07 | 0.49 ± 0.08 | 162.19 ± 55.75 |
| Carbamazepine-10,11- Epoxide | 0.11 ± 0.10 | 0.00 ± 0.01 | 0.31 ± 0.89 | 0.07 ± 0.02 | 0.04 ± 0.01 | 59.32 ± 25.46 |
| Gabapentin | 0.23 ± 0.18 | 0.00 | 0.00 ± 0.00 | 0.25 ± 0.10 | 0.00 ± 0.01 | 0.64 ± 1.70 |
| Lamotrigine | 0.41 ± 0.19 | 0.01 ± 0.01 | 2.42 ± 1.90 | 0.38 ± 0.14 | 0.33 ± 0.09 | 91.97 ± 33.01 |
|
|
|
|
|
|
|
|
| Diclofenac | 1.20 ± 0.71 | 0.00 | 0.00 ± 0.00 | 1.52 ± 0.42 | 0.00 | 0.00 ± 0.00 |
| Ketoprofen | 0.07 ± 0.13 | 0.00 | 0.00 ± 0.00 | 0.19 ± 0.08 | 0.00 | 0.00 ± 0.00 |
| Niflumic Acid | 0.04 ± 0.03 | 0.00 | 0.00 ± 0.00 | 0.07 ± 0.03 | 0.00 ± 0.01 | 1.19 ± 3.15 |
| Tramadol | 0.18 ± 0.09 | 0.00 ± 0.01 | 0.37 ± 1.04 | 0.25 ± 0.20 | 0.11 ± 0.05 | 77.23 ± 57.85 |
|
|
|
|
|
|
|
|
| Atenolol | 0.02 ± 0.03 | 0.00 | 0.00 ± 0.00 | 0.08 ± 0.03 | 0.00 ± 0.01 | 4.80 ± 9.08 |
| Bisoprolol | 0.07 ± 0.07 | 0.00 | 0.00 ± 0.00 | 0.15 ± 0.07 | 0.01 ± 0.01 | 4.20 ± 5.40 |
| Clopidrogel | 0.02 ± 0.01 | 0.00 | 0.00 ± 0.00 | 0.02 ± 0.00 | 0.00 | 0.00 ± 0.00 |
| Fenofibric Acid | 0.04 ± 0.10 | 0.00 | 0.00 ± 0.00 | 0.09 ± 0.08 | 0.00 | 0.00 ± 0.00 |
| Flecainide | 1.76 ± 0.88 | 0.00 ± 0.01 | 0.17 ± 0.47 | 0.99 ± 0.22 | 0.07 ± 0.03 | 6.84 ± 3.05 |
| Irbesartan | 3.36 ± 0.76 | 0.00 | 0.01 ± 0.02 | 1.98 ± 0.75 | 0.14 ± 0.10 | 6.65 ± 4.37 |
| Irbesartan 446 | 0.67 ± 0.16 | 0.00 ± 0.01 | 0.19 ± 0.35 | 0.89 ± 0.56 | 0.24 ± 0.10 | 32.36 ± 16.48 |
| Losartan | 0.06 ± 0.07 | 0.00 | 0.00 ± 0.00 | 0.05 ± 0.03 | 0.00 | 0.00 ± 0.00 |
| Metoprolol | 0.08 ± 0.05 | 0.00 | 0.00 ± 0.00 | 0.08 ± 0.04 | 0.01 ± 0.01 | 17.68 ± 11.79 |
| Metoprolol Acid | 0.18 ± 0.14 | 0.00 | 0.00 ± 0.00 | 0.45 ± 0.23 | 0.03 ± 0.02 | 7.76 ± 5.07 |
| Olmesartan | 3.75 ± 0.74 | 0.01 ± 0.01 | 0.31 ± 0.23 | 3.73 ± 1.35 | 1.36 ± 0.35 | 39.57 ± 11.69 |
| Sotalol | 0.19 ± 0.13 | 0.00 | 0.00 ± 0.00 | 0.14 ± 0.04 | 0.01 ± 0.02 | 7.64 ± 14.18 |
| Telmisartan | 1.11 ± 0.44 | 0.00 | 0.00 ± 0.00 | 0.25 ± 0.15 | 0.00 | 0.00 ± 0.00 |
| Valsartan | 0.31 ± 0.51 | 0.00 | 0.00 ± 0.00 | 0.55 ± 0.58 | 0.00 | 0.00 ± 0.00 |
|
| ||||||
| 2-Phenyl-5-BenzimidazolesulfonicAcid | 3.28 ± 3.77 | 0.00 | 0.00 ± 0.00 | 9.50 ± 9.82 | 0.13 ± 0.23 | 2.74 ± 4.45 |
|
|
|
|
|
|
|
|
| Amisulpride | 0.14 ± 0.07 | 0.00 | 0.00 ± 0.00 | 0.33 ± 0.19 | 0.12 ± 0.05 | 46.44 ± 26.93 |
| EDDP | 0.83 ± 0.38 | 0.00 | 0.00 ± 0.00 | 0.86 ± 0.42 | 0.25 ± 0.14 | 31.37 ± 14.04 |
| Metamphetamine | 0.00 | 0.00 | - | 0.07 ± 0.04 | 0.00 | 0.00 ± 0.00 |
| Sulpride | 0.27 ± 0.14 | 0.001 ± 0.010 | 0.15 ± 0.42 | 0.21 ± 0.07 | 0.14 ± 0.04 | 73.72 ± 38.02 |
| Venlafaxine | 0.31 ± 0.17 | 0.00 | 0.00 ± 0.00 | 0.19 ± 0.09 | 0.09 ± 0.03 | 52.37 ± 24.57 |
|
| ||||||
| Cetirizine | 0.13 ± 0.12 | 0.00 | 0.00 ± 0.00 | 0.10 ± 0.04 | 0.02 ± 0.02 | 22.35 ± 13.14 |
|
| ||||||
| Sitagliptin | 0.87 ± 0.55 | 0.00 | 0.00 ± 0.00 | 0.57 ± 0.12 | 0.11 ± 0.06 | 18.69 ± 8.88 |
|
| ||||||
| Iopromide | 0.02 ± 0.04 | 0.00 | 0.00 ± 0.00 | 0.62 ± 1.11 | 0.00 ± 0.01 | 0.05 ± 0.09 |
Figure 1Concentrations of CECs grouped by pharmaceutical category in the WWTPs’ effluents (TW).
Figure 2Schematic representation of the stratigraphy of the two studied wastewater treatment plants; WWTP-K = effluent flowing into a karst fractured vadose zone; WWTP-P = effluent flowing into a porous vadose zone.
Figure 3Schematic representation of the treatment processes of the two selected wastewater treatment plants; WWTP-K=effluent flowing into a karst fractured vadose zone; WWTP-P=effluent flowing into a porous vadose zone.